Essen, Germany. In light of the evolving COVID-19 situation, our top priority is the health and safety of our colleagues as well as of you, our investors and analysts. We have therefore taken the decision to postpone our Capital Markets Day.
Instead of an in-person meeting in London on April 1st 2020, we will now combine the Capital Markets Day with our Q1 reporting on May 7th. We will host a Conference Call and subsequent Q&A session at 11.00 a.m. CET (10.00 a.m. GMT). The first part of the call will focus on the Q1 results, the second part on the strategic update and our new divisional structure.
All presentations will be available at 07.00 a.m. CET on the IR website.
Thank you for your understanding and we are looking forward to virtually meeting you on May 7th!
Evonik Industries AG
Phone: +49 201 177-3146
Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €13.1 billion and an operating profit (adjusted EBITDA) of €2.15 billion in 2019. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. More than 32,000 employees work together for a common purpose: We want to improve life, day by day.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.